Journal of Affective Disorders
Volume 66, Issue 2 , Pages 193-198 , October 2001

Depression associated with multiple sclerosis: Looking beyond diagnosis to symptom expression

Received 6 January 2000 ,Accepted 24 August 2000.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of the American Psychiatric Association. 4th Edition. Washington DC: APA; 1994;
  2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561–571
  3. DePaulo JR, Folstein MF. Psychiatric disturbance in neurological patients: detection, recognition and hospital course. Ann. Neurology. 1978;4:225–228
  4. DePaulo JR, Folstein MF, Gordon B. Psychiatric screening on a neurological ward. Psychol. Med. 1980;10:125–132
  5. Eriksson E. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int. Clin. Psychopharmacology. 1999;14(Suppl. 2):S27–S33May
  6. Feinstein A, Feinstein KJ, Gray T, O’Connor P. The prevalence and neurobehavioural correlates of pathological laughing and crying in multiple sclerosis. Arch. Neurology. 1997;54:116–121
  7. First MB, Spitzer RL, Gibbom M, Williams J. Structured Clinical Interview for Axis 1 DSM-IV Disorders. New York: Biometrics Research Department, New York State Psychiatric Institute; 1994;Patient Edition (SCID-I/P, Version 2.0)
  8. Goldberg D, Hillier VF. A scaled version of the General Health Questionnaire. Psychol. Med. 1979;9:139–145
  9. Joffe RT, Lippert GP, Gray T, Sawa G, Horvath Z. Mood disorder and multiple sclerosis. Arch. Neurology. 1987;44:376–378
  10. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Am. J. Psychiatry. 1996;153:1411–1417
  11. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al  Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J. Affect. Dis. 1998;50:97–108
  12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  13. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen. Hosp. Psychiatry. 1987;9:426–434
  14. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch. Neurology. 1990;47:98–104
  15. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurology. 1983;13:227–231
  16. Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lafaso D. A randomized trail of nortriptyline for smoking cessation. Arch. Intern. Med. 1998;158:2035–2039
  17. Rabins PV, Brooks BR. Emotional disturbance in multiple sclerosis patients: validity of the General Health Questionnaire (GHQ). Psychol. Med. 1981;11:425–427
  18. Rabins PV, Brooks BR, O’Donnell P, Pearlson GD, Moberg P, Jubelt B, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain. 1986;109:585–597
  19. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns and prediction. Neurology. 1991;41:685–691
  20. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR. Pathological laughing and crying following stroke: validation of a measurement scale and double blind treatment study. Am. J. Psychiatry. 1993;150:286–293
  21. Sherbourne CD, Wells KB, Hays RD, Rogers W, Burnam MA, Judd LL. Subthreshold depression and depressive disorder: clinical characteristics of general medical and mental health speciality outpatients. Am. J. Psychiatry. 1994;151:1777–1784
  22. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathological laughing and weeping with amitriptyline. New Engl. J. Med. 1985;312:1480–1482
  23. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am. J. Psychiatry. 1990;147:1493–1497
  24. Scott TF, Nussbaum P, McConnell H, Brill P. Measurement f treatment response to sertraline in depressed multiple sclerosis patients using the Carrol scale. Neurol. Res. 1995;17:421–422
  25. Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K. Fluoxetine improves emotional incontinence. Brain Inj. 1992;6:267–270
  26. Shafey H. The effect of fluoxetine in depression associated with multiple sclerosis. Can. J. Psychiatry. 1992;37:147–148
  27. Silver JM, Yudowsky SC. Aggressive disorders. In:  Silver JM,  Yudowsky SC,  Hales RE editor. Neuropsychiatry of Traumatic Brain Injury. Washington DC: American Psychiatric Press; 1994;p. 313–353Chapter 10
  28. Surridge D. An investigation into some aspects of multiple sclerosis. Br. J. Psychiatry. 1969;115:749–764
  29. Wells KB. The role of depression in hypertension-related mortality. Psychosom. Med. 1995;57:436–438
  30. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. J. Am. Med. Assoc. 1989;262:914–919

PII: S0165-0327(00)00298-6

Journal of Affective Disorders
Volume 66, Issue 2 , Pages 193-198 , October 2001

Article Tools